A randomised trial of idarubicin dose escalation in consolidation therapy following intensive induction chemotherapy incorporating high dose cytarabine in patients with untreated adult acute myeloid leukaemia, to evaluate safety and improve remission rate.(AMLM12)

Dataset includes: Data for 42 patients Includes first Australian study conducted in AML using dose escalation therapy. Also investigates use of antiemetics and oral mucositis medication Demographic data, diagnostic data, treatment data, outcome data induction and consolidation treatment, including measurements for progression and clinical outcomes. Patients who underwent BMT were censored for this study